(Reuters) - India's patent office has rejected an application from U.S.-based Gilead Sciences Inc for its…
Hepatitis C drug patent
India rejects Gilead’s Hepatitis C drug patent request
As Gilead is the sole producer of sofosbuvir (no generic versions have been launched in any…